Justin Feigelman in

Justin Feigelman

Login to view DISC.
Director, Clinical Pharmacology at Gilead Sciences
📍 San Francisco Bay Area, United States

Justin Feigelman is the Director of Clinical Pharmacology at Gilead Sciences, where he leads the development of Quantitative Systems Pharmacology (QSP) models. His expertise lies in creating complex models for virology and inflammation to support drug development. He holds a PhD from the Technical University of Munich and a B. A. in Physics from UC Berkeley.

He developed a comprehensive QSP model of acute Hepatitis B virus infection to provide mechanistic insights into how the virus progresses and inform the design of novel therapies.

Read the full overview →
Experience
14 Years
Current Role
Director, Clinical Pharmacology
Job Level
Mid-senior
Location
San Francisco Bay Area, United States
Personality Overview

How Justin shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Justin cares about

Quantitative Systems Pharmacology
He leads a QSP group at Gilead, has numerous publications on the topic, and is focused on applying these models to support clinical programs and decision-making.
Viral Dynamics Modeling
His recent publications focus on creating detailed models of Hepatitis B and HIV to understand the interplay between viral replication, immune response, and therapeutic interventions.
+5 more topics Login to view topics
Career

Work history

9-2024
Director, Clinical Pharmacology
Gilead Sciences
9-2023
Sr. Clinical Pharmacologist II
Gilead Sciences
5-2022 - 9-2023
Associate Director of Quantitative Pharmacology
Regeneron
5-2021 - 5-2022
Senior Scientist, Modeling and Simulation
Genentech
10-2019 - 5-2021
Scientist, Modeling and Simulation
Genentech
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2011 - 2015
Doctor of Philosophy (PhD)
Technical University of Munich
2009 - 2011
MS
ETH Zürich
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Gilead Sciences Employees

Explore more public profiles from related professionals.

Josephine Yang Comiskey
Josephine Yang Comiskey
Senior Vice President, Australia-Canada-Europe
Gilead Sciences
 Angela Scott-Silva, PhD
Angela Scott-Silva, PhD
Global Head of Medical Writing, Executive Director
Gilead Sciences
 Nancy Jackson
Nancy Jackson
Executive Director, Regulatory Submission Management
Gilead Sciences
 Jason Moyer
Jason Moyer
Executive Director Regulatory Affairs Innovation, Digital, and External Partnerships
Gilead Sciences

More profiles

Discover additional public profiles from our index.

Jacek Urbanek
Jacek Urbanek
Director Biostatistics
Regeneron
EC
Emily Carter
Reproduction technician/photographer
Kimber Manufacturing
 Colum Reilly
Colum Reilly
Head of Information Technology Operations
Dunnes Stores
 Shaun Jensen
Shaun Jensen
Director of Information Technology
Knight's Armament Company
Unlock the full playbookSee exactly how to sell to Justin. Free, 10 seconds.